Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EAAT2 modulators(solute carrier family 1 member 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC20H25N7 |
InChIKeyVGNIHZIDQKBDHQ-UHFFFAOYSA-N |
CAS Registry2585643-97-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Discovery | US | 16 Apr 2024 |